Management of heartburn not responding to proton pump inhibitors

被引:240
作者
Fass, R. [1 ]
Sifrim, D. [2 ]
机构
[1] Univ Arizona, Neuroenter Clin Res Grp, So Arizona VA Hlth Care Syst, Tucson, AZ 85723 USA
[2] Catholic Univ Louvain, Ctr Gastroenterol Res, B-3000 Louvain, Belgium
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; DILATED INTERCELLULAR SPACES; MULTICHANNEL INTRALUMINAL IMPEDANCE; ESOPHAGEAL SPHINCTER RELAXATIONS; GABA(B) AGONIST BACLOFEN; GASTRIC-ACID-SECRETION; EOSINOPHILIC ESOPHAGITIS; BARRETTS-ESOPHAGUS; DOUBLE-BLIND; FOLLOW-UP;
D O I
10.1136/gut.2007.145581
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with gastro-oesophageal reflux disease (GORD) who are not responding to proton pump inhibitors (PPIs) given once daily are very common. Various underlying mechanisms have been shown to contribute to the failure of PPI treatment. These include weakly acidic reflux, duodenogastro-oesophageal reflux, residual acid reflux and functional heartburn, as well as others. Diagnostic evaluation of patients with GORD who have failed PPI treatment may include an upper endoscopy, pH testing and oesophageal impedance with pH monitoring. Commonly, doubling the PPI dose or switching to another PPI will be pursued by the treating physician. Failure of such a therapeutic strategy may result in the addition of a transient lower oesophageal sphincter reducer or pain modulator. Anti-reflux surgery may be suitable for a subset of carefully studied patients.
引用
收藏
页码:295 / 309
页数:15
相关论文
共 135 条
[1]   Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis [J].
Adachi, K ;
Fujishiro, H ;
Katsube, T ;
Yuki, M ;
Ono, M ;
Kawamura, A ;
Rumi, MAK ;
Watanabe, M ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (11) :1191-1196
[2]  
Bardan E, 2007, GASTROENTEROLOGY, V132, pA488
[3]   The pathogenesis of heartburn in nonerosive reflux disease: A unifying hypothesis [J].
Barlow, WJ ;
Orlando, RC .
GASTROENTEROLOGY, 2005, 128 (03) :771-778
[4]   The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications [J].
Bautista, JM ;
Wong, WM ;
Pulliam, G ;
Esquivel, RF ;
Fass, R .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) :1909-1915
[5]   Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy [J].
Becker, V. ;
Bajbouj, M. ;
Waller, K. ;
Schmid, R. M. ;
Meining, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (10) :1355-1360
[6]  
BEHAR J, 1975, ARCH PATHOL, V99, P387
[7]   Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough [J].
Blondeau, K. ;
Dupont, L. J. ;
Mertens, V. ;
Tack, J. ;
Sifrim, D. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (06) :723-732
[8]   Proton pump inhibitor-therapy refractory gastro-oesophageal reflux disease patients, who are they? [J].
Bredenoord, Albert J. ;
Dent, John .
GUT, 2007, 56 (04) :593-594
[9]   Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment [J].
Calabrese, C ;
Bortolotti, M ;
Fabbri, A ;
Areni, A ;
Cenacchi, G ;
Scialpi, C ;
Miglioli, M ;
Di Febo, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03) :537-542
[10]   Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole [J].
Carlsson, R ;
Dent, J ;
Watts, R ;
Riley, S ;
Sheikh, R ;
Hatlebakk, J ;
Haug, K ;
de Groot, G ;
van Oudvorst, A ;
Dalvag, A ;
Junghard, O ;
Wiklund, I .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (02) :119-124